Patents by Inventor C. Matthew PETERSON

C. Matthew PETERSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polymeric drug delivery conjugates and methods of making and using thereof
    Patent number: 12350337
    Abstract: Described herein are biodegradable drug delivery conjugates and anti-cancer conjugates for effectively delivering anti-cancer agents to a subject. The conjugates include a single first cleavable peptide linker covalently connected to two polymeric segments, wherein at least one PD-L1 inhibitor is covalently bonded to each polymeric segment (referred to herein as “a PD-L1 inhibitor polymer conjugate”). Also described herein is the use of the PD-L1 inhibitor polymer conjugates in combination with anticancer agents to treat or prevent cancer.
    Type: Grant
    Filed: October 16, 2020
    Date of Patent: July 8, 2025
    Assignee: UNIVERSITY OF UTAH RESEARCH FOUNDATION
    Inventors: Jiyuan Yang, Lian Li, C. Matthew Peterson, Jindrich Kopecek
  • POLYMERIC DRUG DELIVERY CONJUGATES AND METHODS OF MAKING AND USING THEREOF
    Publication number: 20220249682
    Abstract: Described herein are biodegradable drug delivery conjugates and anti-cancer conjugates for effectively delivering anti-cancer agents to a subject. The conjugates include a single first cleavable peptide linker covalently connected to two polymeric segments, wherein at least one PD-L1 inhibitor is covalently bonded to each polymeric segment (referred to herein as “a PD-L1 inhibitor polymer conjugate”). Also described herein is the use of the PD-L1 inhibitor polymer conjugates in combination with anticancer agents to treat or prevent cancer.
    Type: Application
    Filed: October 16, 2020
    Publication date: August 11, 2022
    Inventors: Jiyuan YANG, Lian LI, C. Matthew PETERSON, Jindrich KOPECEK